Neutropenia  >>  oxaliplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

11 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT01286818: A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)

Checkmark ASCO-GI 2013
Jan 2013 - Jan 2013: ASCO-GI 2013
Completed
1b
6
Japan
Ramucirumab (IMC-1121B), IMC-1121B, Ramucirumab, LY3009806, Irinotecan, levofolinate, 5-Fluorouracil (5-FU)
Eli Lilly and Company
Colorectal Carcinoma
02/12
03/12
Javelin DLBCL, NCT02951156 / 2016-002904-15: Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

Terminated
1b
29
Europe, US, RoW
Avelumab, MSB0010718C, Utomilumab, PF-05082566, Rituximab, Rituxan, Azacitidine, Vidaza, Bendamustine, Treanda, Gemcitabine, Gemzar, Oxaliplatin, Eloxatin
Pfizer, EMD Serono
Diffuse Large B-Cell Lymphoma
12/19
12/19
NCT00446290: Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

Completed
1
22
RoW
Docetaxel, Capecitabine and Oxaliplatin
Asan Medical Center
Stomach Cancer
10/07
10/07
NCT01561014: Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Completed
1
9
US
erlotinib hydrochloride, CP-358,774, erlotinib, OSI-774, oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, radiation therapy, irradiation, radiotherapy, therapy, radiation, conventional surgery, surgery, conventional, immunohistochemistry staining method, immunohistochemistry, positron emission tomography, FDG-PET, PET, PET scan, tomography, emission computed, computed tomography, tomography, computed, laboratory biomarker analysis, gene expression analysis, fludeoxyglucose F 18, 18FDG, FDG
Wake Forest University Health Sciences, National Cancer Institute (NCI)
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Squamous Cell Carcinoma of the Esophagus, Stage II Esophageal Cancer, Stage II Gastric Cancer, Stage III Esophageal Cancer, Stage III Gastric Cancer
03/09
03/09
NCT00555620: Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer

Checkmark Sunitinib+capecitabine/cisplatin OR capecitabine/oxaliplatin in adv gastric cancer
Oct 2013 - Oct 2013: Sunitinib+capecitabine/cisplatin OR capecitabine/oxaliplatin in adv gastric cancer
Completed
1
76
RoW
capecitabine, oxaliplatin, sunitinib malate, Sutent, cisplatin
Pfizer
Stomach Neoplasms
08/10
12/11
NCT01164215: Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy

Completed
1
76
US
fluorouracil, 5FU, leucovorin, leucovorin calcium, oxaliplatin, Eloxatin
UNC Lineberger Comprehensive Cancer Center, National Cancer Institute (NCI)
Colorectal Cancer, Diarrhea, Neutropenia
11/12
09/13
NCT02062749: Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma

Completed
1
1
US
Oxaliplatin, Eloxatin
M.D. Anderson Cancer Center
Colorectal Cancer
06/18
06/18
NCT01213238: Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab

Completed
1
116
US
Oxaliplatin, Eloxatin, Capecitabine, Xeloda, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAb-VEGF
M.D. Anderson Cancer Center
Advanced Cancers
09/18
09/18
NCT03503604: A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Unknown status
1
18
RoW
hPV19 mAb, anti-VEGF mAb, 5-Fluorouracil, Oxaliplatin, Leucovorin, Paclitaxel, Carboplatin, Gemcitabine, Irinotecan
SuZhou Stainwei Biotech Inc.
Solid Tumors
01/19
03/19
ACTRN12618000232235: Ibudilast for the prevention of nerve symptoms caused by oxalipatin chemotherapy, in patients with metastatic gastrointestinal cancer

Completed
1
20
 
Concord Cancer Centre, Concord Cancer Centre
Acute neurotoxicity , Chemotherapy induced peripheral neuropathy (CIPN), Metastatic gastrointestinal cancer
 
 
FIGHT, NCT03343301: A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

Checkmark From FIGHT study for advanced solid tumors & FGFR2b-selected gastroesophageal adenocarcinoma
Mar 2020 - Mar 2020: From FIGHT study for advanced solid tumors & FGFR2b-selected gastroesophageal adenocarcinoma
Checkmark Completed P1 portion for gastric/gastroesophageal cancer [FIGHT]
Sep 2018 - Sep 2018: Completed P1 portion for gastric/gastroesophageal cancer [FIGHT]
Completed
1
12
US
Bemarituzumab, FPA144, Modified FOLFOX6, mFOLFOX6
Five Prime Therapeutics, Inc.
Gastrointestinal Cancer, Gastrointestinal Cancer Metastatic, Gastric Cancer
01/19
01/19

Download Options